• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Baxter International

Baxter International

Baxter International Inc BAX 4 Star

Last Price$74.55Day Change (%)-0.20%
Open Price$74.74Day Change ($)-0.15
Day Range74.08–74.7452-Week Range62.80–77.31

As of Mon 09/15/2014 03:39 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. FDA Approves Baxter ’s HYQVIA for Treatment of Adults with Primary Immunodeficiency

    FDA Approves Baxter ’s HYQVIA for Treatment of Adults with Primary Immunodeficiency

  2. Research and Markets: Pharmacy Automation Systems Market to 2019: Medication Dispensing Systems, Packaging and Labeling Systems & Table-top Counters Analysis

    Research and Markets: Pharmacy Automation Systems Market to 2019: Medication Dispensing Systems, Packaging and Labeling Systems & Table-top Counters Analysis

  3. Research and Markets: Global Wound Care (Wound Closure, Anti infective) Market - Forecast to 2019

    Research and Markets: Global Wound Care (Wound Closure, Anti infective) Market - Forecast to 2019

  4. Research and Markets: Asia-Pacific Infusion Therapy Device Market - Executive Summary Report 2014

    Research and Markets: Asia-Pacific Infusion Therapy Device Market - Executive Summary Report 2014

  5. Moats and Growth Drivers Look Solid for Post-Split Baxter

    Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.

  6. Ipsen: 2014 Half-Year Results and 2014 Objectives

    Ipsen: 2014 Half-Year Results and 2014 Objectives

  7. Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

    Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

  8. Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

    Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

  9. USIBC Concludes Successful Medical Device Mission to India

    USIBC Concludes Successful Medical Device Mission to India

  10. Strong Pipeline Helps Protect Baxter's Wide Moat From Competition

    The diversified health-care firm remains remarkably profitable in tough industries.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.